Pharmaceutical Compositions Comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)

Abstract

The present invention relates to pharmaceutical compositions comprising the NK1 receptor antagonist [2-Methoxy-5-(5-trifuoromethyl-tetrazol-1-yl)-benzyl]-(2S-phenyl- piperidin-3S-yl)-amine, or a pharmaceutically acceptable salt or solvate thereof, and a sodium channel blocker, as a combined preparation for simultaneous or sequential administration and to the use of such compositions in the treatment of certain disorders, including epilepsy, mood disorders and pain.


Claims
Download PDF
Document Preview
Document History
  • Publication: Jul 31, 2008
  • Application: Jan 21, 2008
    WO EP 2008050621 W
  • Priority: Jan 24, 2007
    GB GB 0701364 A
  • Priority: Jan 24, 2007
    GB GB 0701365 A
  • Priority: Jan 24, 2007
    GB GB 0701366 A
  • Priority: Jan 24, 2007
    GB GB 0701367 A
  • Priority: Jan 24, 2007
    GB GB 0701368 A

Download Citation


Sign in to the Lens

Feedback